India Intravenous Solutions Market Report and Forecast 2025-2034
Description
The India intravenous solutions market size was valued at INR 171.44 Billion in 2024, driven by its wide utility in various healthcare domains ranging from surgical to post-surgical care across the region. The market is expected to grow at a CAGR of 8.30% during the forecast period of 2025-2034, with the values likely to rise from INR 380.54 Billion by 2034.
Intravenous Solutions: Introduction
Intravenous solutions are injected into a patient’s vein to prevent or treat electrolyte imbalance or dehydration in the body. It is injected through an IV (intravenous) tube. It may be used to restore electrolytes in people who are suffering from diarrhea or vomiting, have exercised too much, have burns or serious injuries, or have undergone surgery. Intravenous solutions contain various nutrients. The three main types of intravenous solutions are hypotonic, isotonic, and hypertonic.
India Intravenous Solutions Market Analysis
The development of the healthcare infrastructure in the country is a key trend supporting the growth of the India intravenous solutions market value. With more hospitals and medical care centres available across the country, including in smaller towns, the demand for intravenous solutions is expected to rise. In addition, there is a heightened focus on providing apt neonatal care to decrease the infant mortality rate. As intravenous solutions provide instant effect, they have been widely adopted to treat malnutrition in infants, women as well as children in the region.
The rising prevalence of cancer is another factor contributing to the market growth. Treatments like radiation and chemotherapy also rely on intravenous solutions for efficient response.
Specific programs like the Rashtriya Kishor Swasthya Karyakram, Ayushman Bharat which includes PM-JAY, India’s biggest government sponsored health insurance scheme, along with the National Digital Health Mission have been initiated by the government to make the masses informed and empowered to make appropriate health decisions. There is another allocation INR 5,000 crore to boost the medical healthcare research and development in pharmaceutical sector. Moreover, with the integration of latest technologies like artificial intelligence and data analytics in medical ecosystem, we can expect the India intravenous solutions market share to expand globally as well.
India Intravenous Solutions Market Segmentation
India Intravenous Solutions Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type of Intravenous Solutions
India intravenous solutions market demand has observed a significant upswing, owing to their increased application in several healthcare conditions, including surgery, chemotherapy, blood transfusions as well as emergency medicines. This increased usage can be accredited to its relatively higher efficacy and rapid response capabilities to those in need. Moreover, the population dynamics of the region are quite diverse, ranging from pediatrics to geriatrics. Intravenous solutions, being easily accessible and affordable, are heavily used to cater to different dynamics.
India intravenous solutions market growth is driven by a diverse range of government as well as private sector initiatives to improve the healthcare system, build high-capacity hospitals and clinics for increasing population and facilitate better public health opportunities. In addition, there is high emphasis on inviting Foreign Direct Investment (FDI) with a vision to foster growth in the healthcare sector.
India Intravenous Solutions Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Intravenous Solutions: Introduction
Intravenous solutions are injected into a patient’s vein to prevent or treat electrolyte imbalance or dehydration in the body. It is injected through an IV (intravenous) tube. It may be used to restore electrolytes in people who are suffering from diarrhea or vomiting, have exercised too much, have burns or serious injuries, or have undergone surgery. Intravenous solutions contain various nutrients. The three main types of intravenous solutions are hypotonic, isotonic, and hypertonic.
India Intravenous Solutions Market Analysis
The development of the healthcare infrastructure in the country is a key trend supporting the growth of the India intravenous solutions market value. With more hospitals and medical care centres available across the country, including in smaller towns, the demand for intravenous solutions is expected to rise. In addition, there is a heightened focus on providing apt neonatal care to decrease the infant mortality rate. As intravenous solutions provide instant effect, they have been widely adopted to treat malnutrition in infants, women as well as children in the region.
The rising prevalence of cancer is another factor contributing to the market growth. Treatments like radiation and chemotherapy also rely on intravenous solutions for efficient response.
Specific programs like the Rashtriya Kishor Swasthya Karyakram, Ayushman Bharat which includes PM-JAY, India’s biggest government sponsored health insurance scheme, along with the National Digital Health Mission have been initiated by the government to make the masses informed and empowered to make appropriate health decisions. There is another allocation INR 5,000 crore to boost the medical healthcare research and development in pharmaceutical sector. Moreover, with the integration of latest technologies like artificial intelligence and data analytics in medical ecosystem, we can expect the India intravenous solutions market share to expand globally as well.
India Intravenous Solutions Market Segmentation
India Intravenous Solutions Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type of Intravenous Solutions
- Crystalloids
- Colloids
- Parenteral Nutrition Solutions
- Blood-Derived Products
- Others
- Fluid Replacement Therapy
- Electrolyte Imbalance Correction
- Blood Transfusion
- Parenteral Nutrition
- Chemotherapy
- Rehydration
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Home Healthcare Settings
India intravenous solutions market demand has observed a significant upswing, owing to their increased application in several healthcare conditions, including surgery, chemotherapy, blood transfusions as well as emergency medicines. This increased usage can be accredited to its relatively higher efficacy and rapid response capabilities to those in need. Moreover, the population dynamics of the region are quite diverse, ranging from pediatrics to geriatrics. Intravenous solutions, being easily accessible and affordable, are heavily used to cater to different dynamics.
India intravenous solutions market growth is driven by a diverse range of government as well as private sector initiatives to improve the healthcare system, build high-capacity hospitals and clinics for increasing population and facilitate better public health opportunities. In addition, there is high emphasis on inviting Foreign Direct Investment (FDI) with a vision to foster growth in the healthcare sector.
India Intravenous Solutions Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Piramal Enterprises Limited
- Hospira (Pfizer Inc.)
- Amsino International Inc.
- ICU Medical, Inc.
- Sami Labs Limited
- Troikaa Pharmaceuticals Ltd.
- Neiss Labs Pvt. Ltd.
- Ketan Pharma
- Abaris Healthcare Pvt. Ltd.
- Parenteral Drugs (India) Ltd.
- Arbro Pharmaceuticals Limited
- Neon Laboratories Ltd.
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
200 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 India Intravenous Solutions Market Overview
- 3.1 India Intravenous Solutions Market Historical Value (2018-2024)
- 3.2 India Intravenous Solutions Market Forecast Value (2025-2034)
- 4 India Intravenous Solutions Market Landscape
- 4.1 India Intravenous Solutions Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 India Intravenous Solutions Product Landscape
- 4.2.1 Analysis by Product Type
- 4.2.2 Analysis by Applications
- 5 India Intravenous Solutions Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 India Intravenous Solutions Market Segmentation
- 6.1 India Intravenous Solutions Market by Type of Intravenous Solutions
- 6.1.1 Market Overview
- 6.1.2 Crystalloids
- 6.1.3 Colloids
- 6.1.4 Parenteral Nutrition Solutions
- 6.1.5 Blood-Derived Products
- 6.1.6 Others
- 6.2 India Intravenous Solutions Market by Application
- 6.2.1 Market Overview
- 6.2.2 Fluid Replacement Therapy
- 6.2.3 Electrolyte Imbalance Correction
- 6.2.4 Blood Transfusion
- 6.2.5 Parenteral Nutrition
- 6.2.6 Chemotherapy
- 6.2.7 Rehydration
- 6.3 India Intravenous Solutions Market by End-User
- 6.3.1 Market Overview
- 6.3.2 Hospitals
- 6.3.3 Clinics
- 6.3.4 Ambulatory Surgical Centres
- 6.3.5 Home Healthcare Settings
- 7 Patent Analysis
- 7.1 Analysis by Type of Patent
- 7.2 Analysis by Publication year
- 7.3 Analysis by Issuing Authority
- 7.4 Analysis by Patent Age
- 7.5 Analysis by CPC Analysis
- 7.6 Analysis by Patent Valuation
- 7.7 Analysis by Key Players
- 8 Grants Analysis
- 8.1 Analysis by year
- 8.2 Analysis by Amount Awarded
- 8.3 Analysis by Issuing Authority
- 8.4 Analysis by Grant Application
- 8.5 Analysis by Funding Institute
- 8.6 Analysis by NIH Departments
- 8.7 Analysis by Recipient Organization
- 9 Regulatory Framework
- 10 Suppliers Landscape
- 10.1 Baxter International Inc.
- 10.1.1 Financial Analysis
- 10.1.2 Product Portfolio
- 10.1.3 Demographic Reach and Achievements
- 10.1.4 Mergers and Acquisitions
- 10.1.5 Certifications
- 10.2 B. Braun Melsungen AG
- 10.2.1 Financial Analysis
- 10.2.2 Product Portfolio
- 10.2.3 Demographic Reach and Achievements
- 10.2.4 Mergers and Acquisitions
- 10.2.5 Certifications
- 10.3 Fresenius SE & Co. KGaA
- 10.3.1 Financial Analysis
- 10.3.2 Product Portfolio
- 10.3.3 Demographic Reach and Achievements
- 10.3.4 Mergers and Acquisitions
- 10.3.5 Certifications
- 10.4 Piramal Enterprises Limited
- 10.4.1 Financial Analysis
- 10.4.2 Product Portfolio
- 10.4.3 Demographic Reach and Achievements
- 10.4.4 Mergers and Acquisitions
- 10.4.5 Certifications
- 10.5 Hospira (Pfizer Inc.)
- 10.5.1 Financial Analysis
- 10.5.2 Product Portfolio
- 10.5.3 Demographic Reach and Achievements
- 10.5.4 Mergers and Acquisitions
- 10.5.5 Certifications
- 10.6 Amsino International Inc.
- 10.6.1 Financial Analysis
- 10.6.2 Product Portfolio
- 10.6.3 Demographic Reach and Achievements
- 10.6.4 Mergers and Acquisitions
- 10.6.5 Certifications
- 10.7 ICU Medical, Inc.
- 10.7.1 Financial Analysis
- 10.7.2 Product Portfolio
- 10.7.3 Demographic Reach and Achievements
- 10.7.4 Mergers and Acquisitions
- 10.7.5 Certifications
- 10.8 Sami Labs Limited
- 10.8.1 Financial Analysis
- 10.8.2 Product Portfolio
- 10.8.3 Demographic Reach and Achievements
- 10.8.4 Mergers and Acquisitions
- 10.8.5 Certifications
- 10.9 Troikaa Pharmaceuticals Ltd.
- 10.9.1 Financial Analysis
- 10.9.2 Product Portfolio
- 10.9.3 Demographic Reach and Achievements
- 10.9.4 Mergers and Acquisitions
- 10.9.5 Certifications
- 10.10 Neiss Labs Pvt. Ltd.
- 10.10.1 Financial Analysis
- 10.10.2 Product Portfolio
- 10.10.3 Demographic Reach and Achievements
- 10.10.4 Mergers and Acquisitions
- 10.10.5 Certifications
- 10.11 Ketan Pharma
- 10.11.1 Financial Analysis
- 10.11.2 Product Portfolio
- 10.11.3 Demographic Reach and Achievements
- 10.11.4 Mergers and Acquisitions
- 10.11.5 Certifications
- 10.12 Abaris Healthcare Pvt. Ltd.
- 10.12.1 Financial Analysis
- 10.12.2 Product Portfolio
- 10.12.3 Demographic Reach and Achievements
- 10.12.4 Mergers and Acquisitions
- 10.12.5 Certifications
- 10.13 Parenteral Drugs (India) Ltd.
- 10.13.1 Financial Analysis
- 10.13.2 Product Portfolio
- 10.13.3 Demographic Reach and Achievements
- 10.13.4 Mergers and Acquisitions
- 10.13.5 Certifications
- 10.14 Arbro Pharmaceuticals Limited
- 10.14.1 Financial Analysis
- 10.14.2 Product Portfolio
- 10.14.3 Demographic Reach and Achievements
- 10.14.4 Mergers and Acquisitions
- 10.14.5 Certifications
- 10.15 Neon Laboratories Ltd.
- 10.15.1 Financial Analysis
- 10.15.2 Product Portfolio
- 10.15.3 Demographic Reach and Achievements
- 10.15.4 Mergers and Acquisitions
- 10.15.5 Certifications
- 11 India Intravenous Solutions Market - Distribution Model (Additional Insight)
- 11.1 Overview
- 11.2 Potential Distributors
- 11.3 Key Parameters for Distribution Partner Assessment
- 12 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 13 Company Competitiveness Analysis (Additional Insight)
- 13.1 Very Small Companies
- 13.2 Small Companies
- 13.3 Mid-Sized Companies
- 13.4 Large Companies
- 13.5 Very Large Companies
- 14 Payment Methods (Additional Insight)
- 14.1 Government Funded
- 14.2 Private Insurance
- 14.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
